Quest Diagnostics (DGX) PT Raised to $250 at UBS

October 19, 2026 9:12 AM

UBS analyst Kevin Caliendo raised the price target on Quest Diagnostics (NYSE: DGX) to $250.00 (from $245.00) while maintaining a Neutral rating.

No results found